AR and seminoma: Changes in the length of these polymorphic trinucleotide repeats lead to AR altered transactivation, and it has been reported as strongly associated with the increased risk to develop seminoma, suggesting that AR increased transactivation may occur in the development of seminoma and/or in the progression of carcinoma in situ to seminoma [55].